Tenaya Therapeutics Inc (NASDAQ: TNYA) on Monday, soared 4.13% from the previous trading day, before settling in for the closing price of $0.68. Within the past 52 weeks, TNYA’s price has moved between $0.36 and $4.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -15.48% annually for the last half of the decade. The company achieved an average annual earnings per share of 40.19%. With a float of $134.18 million, this company’s outstanding shares have now reached $162.66 million.
In an organization with 97 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 17.51%, while institutional ownership is 27.55%. The most recent insider transaction that took place on May 16 ’25, was worth 615. In this transaction SVP, Finance of this company sold 1,390 shares at a rate of $0.44, taking the stock ownership to the 98,300 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Medical Officer sold 2,937 for $0.44, making the entire transaction worth $1,300. This insider now owns 171,856 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 40.19% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 6.68 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.3 million. That was inferior than the volume of 2.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 87.17%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 42.34%, which indicates a significant decrease from 88.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0525 in the past 14 days, which was lower than the 0.0591 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5455, while its 200-day Moving Average is $1.2493. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $0.7365. Second resistance stands at $0.7615. The third major resistance level sits at $0.7915. If the price goes on to break the first support level at $0.6815, it is likely to go to the next support level at $0.6515. Assuming the price breaks the second support level, the third support level stands at $0.6265.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 115.72 million based on 162,667K outstanding shares. Right now, sales total 0 K and income totals -111,130 K. The company made 0 K in profit during its latest quarter, and -26,860 K in sales during its previous quarter.
